TY  - GEN
AU  - Snuderl,Matija
AU  - Kolman,Olga K
AU  - Chen,Yi-Bin
AU  - Hsu,Jessie J
AU  - Ackerman,Adam M
AU  - Dal Cin,Paola
AU  - Ferry,Judith A
AU  - Harris,Nancy Lee
AU  - Hasserjian,Robert P
AU  - Zukerberg,Lawrence R
AU  - Abramson,Jeremy S
AU  - Hochberg,Ephraim P
AU  - Lee,Hang
AU  - Lee,Alfred I
AU  - Toomey,Christiana E
AU  - Sohani,Aliyah R
TI  - B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma
SN  - 1532-0979
PY  - 2010///0319
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Burkitt Lymphoma
KW  - classification
KW  - Child
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - Gene Rearrangement, B-Lymphocyte, Heavy Chain
KW  - Genes, Immunoglobulin Heavy Chain
KW  - Humans
KW  - Immunophenotyping
KW  - In Situ Hybridization, Fluorescence
KW  - Kaplan-Meier Estimate
KW  - Karyotyping
KW  - Lymphoma, B-Cell
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Polymerase Chain Reaction
KW  - Predictive Value of Tests
KW  - Proportional Hazards Models
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - genetics
KW  - Proto-Oncogene Proteins c-myc
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Terminology as Topic
KW  - Time Factors
KW  - Treatment Outcome
KW  - World Health Organization
KW  - Young Adult
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/PAS.0b013e3181cd3aeb
ER  -